Oppenheimer analysts reiterated a Outperform rating on Boston Scientific Corporation (NYSE:BSX) on January 16, 2026. Boston Scientific Corporation operates in the Healthcare…
Oppenheimer analysts reiterated a Outperform rating on Boston Scientific Corporation (NYSE:BSX) on January 16, 2026.
Boston Scientific Corporation operates in the Healthcare sector. The stock currently trades at $88.07 with a market capitalization of $135,976,996,027.
Current market data
NYSE · BSX
$44.11
Down: -$0.43 · -0.97%
Live quote updated
Keep reading
insider ·
insider ·
institutional ·
sec_filing ·
